Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(38%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
1
13%
Ph not_applicable
4
50%
Ph phase_1
1
13%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(2)
Other(2)

Detailed Status

unknown2
Completed2
Recruiting2
Active, not recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
N/A4 (66.7%)

Trials by Status

unknown225%
completed225%
recruiting225%
active_not_recruiting113%
enrolling_by_invitation113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
8